We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Invasive recurrence after breast conserving treatment of ductal carcinoma in situ of the breast in the Netherlands: time trends and the association with tumour grade

    Background

    The first aim of this study was to examine trends in the risk of ipsilateral invasive breast cancer (iIBC) after breast-conserving surgery...

    Rebecca L. O’Leary, Lucien E. M. Duijm, ... Adri C. Voogd in British Journal of Cancer
    Article 09 July 2024
  2. Fitness costs of Tn1546-type transposons harboring the vanA operon by plasmid type and structural diversity in Enterococcus faecium

    Background

    This study analyzed the genetic traits and fitness costs of vancomycin-resistant Enterococcus faecium (VREfm) blood isolates carrying Tn 1546...

    Dokyun Kim, Da Young Kang, ... Seok Hoon Jeong in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 08 July 2024
  3. Impact of the COVID-19 pandemic on extended-spectrum β-lactamase producing Escherichia coli in urinary tract and blood stream infections: results from a nationwide surveillance network, Finland, 2018 to 2022

    Background

    Before the COVID-19 pandemic there has been a constant increase in antimicrobial resistance (AMR) of Escherichia coli , the most common...

    Heikki Ilmavirta, Jukka Ollgren, ... Outi Lyytikäinen in Antimicrobial Resistance & Infection Control
    Article Open access 06 July 2024
  4. Development and validation of machine learning models to predict MDRO colonization or infection on ICU admission by using electronic health record data

    Background

    Multidrug-resistant organisms (MDRO) pose a significant threat to public health. Intensive Care Units (ICU), characterized by the extensive...

    Yun Li, Yuan Cao, ... Hongjun Kang in Antimicrobial Resistance & Infection Control
    Article Open access 06 July 2024
  5. Secondary attack rate following on-site isolation of patients with suspected COVID-19 in multiple-bed rooms

    The implementation of isolation precautions for patients with suspected Coronavirus Disease 2019 (COVID-19) and pending test results is resource...

    Silvio Ragozzino, Richard Kuehl, ... Sarah Tschudin-Sutter in Antimicrobial Resistance & Infection Control
    Article Open access 06 July 2024
  6. Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology – an analysis of the closed cohorts of a multicentre prospective study

    Background

    Therapeutic drug monitoring (TDM) – performing dose adjustments based on measured drug levels and established pharmacokinetic (PK) targets...

    Maud B. A. van der Kleij, Niels A. D. Guchelaar, ... Neeltje Steeghs in British Journal of Cancer
    Article Open access 06 July 2024
  7. Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study

    Importance

    Intra-arterial therapies(IATs) are promising options for unresectable hepatocellular carcinoma(HCC). Stratifying the prognostic risk before...

    Chao An, Ran Wei, ... Jianjun Han in British Journal of Cancer
    Article 06 July 2024
  8. PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers

    Background

    Combining PARP inhibitors (PARPis) with immune checkpoint inhibitors may improve clinical outcomes in selected cancers. We evaluated...

    Rebecca Kristeleit, Alexandra Leary, ... Linda Mileshkin in British Journal of Cancer
    Article Open access 06 July 2024
  9. HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer

    Background

    Resistance to chemotherapy is a major problem in the treatment of patients with triple-negative breast cancer (TNBC). Preclinical data...

    Andrej Besse, Lenka Sedlarikova, ... Lenka Besse in British Journal of Cancer
    Article Open access 05 July 2024
  10. Metabolic adaptations in prostate cancer

    Prostate cancer is one of the most commonly diagnosed cancers in men and is a major cause of cancer-related deaths worldwide. Among the molecular...

    Mikel Pujana-Vaquerizo, Laura Bozal-Basterra, Arkaitz Carracedo in British Journal of Cancer
    Article Open access 05 July 2024
  11. Cancer cell extravasation requires iplectin-mediated delivery of MT1-MMP at invadopodia

    Background

    Invadopodia facilitate cancer cell extravasation, but the molecular mechanism whereby invadopodia-specific proteases such as MT1-MMP are...

    Olivia R. Grafinger, John J. Hayward, ... Hon S. Leong in British Journal of Cancer
    Article 05 July 2024
  12. Embedding community and public voices in co-created solutions to mitigate antimicrobial resistance (AMR) in Thailand using the ‘Responsive Dialogues’ public engagement framework

    The use of antimicrobials in Thailand has been reported as one of the highest in the world in human and animal sectors. Our engagement project aimed...

    Tassawan Poomchaichote, Niyada Kiatying-Angsulee, ... Phaik Yeong Cheah in Antimicrobial Resistance & Infection Control
    Article Open access 04 July 2024
  13. Potent synergy and sustained bactericidal activity of polymyxins combined with Gram-positive only class of antibiotics versus four Gram-negative bacteria

    Background

    Gram-negative bacteria (GNB) are becoming increasingly resistant to a wide variety of antibiotics. There are currently limited treatments...

    Yan Wang, Jianwen Feng, ... Zhihui Jiang in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 04 July 2024
  14. ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors

    Purpose

    PARP inhibitors (PARPi) are effective in homologous recombination repair (HRR) defective (HRD) cancers. To (re)sensitise HRR proficient (HRP)...

    Hannah L. Smith, Elaine Willmore, ... Nicola J. Curtin in British Journal of Cancer
    Article Open access 04 July 2024
  15. Colistin-, cefepime-, and levofloxacin-resistant Salmonella enterica serovars isolated from Egyptian chicken carcasses

    Objectives

    The emergence of multidrug-resistant (MDR) Salmonella strains, especially resistant ones toward critically important antimicrobial classes...

    Bassant Ashraf El-Saeed, Hend Ali Elshebrawy, ... Khalid Ibrahim Sallam in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 04 July 2024
  16. Genomic characterization of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) strains circulating in three university hospitals in Northern Italy over three years

    Objectives

    Genomic surveillance of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) is crucial for virulence,...

    Valeria Fox, Davide Mangioni, ... Claudia Alteri in Antimicrobial Resistance & Infection Control
    Article Open access 03 July 2024
  17. Efficacy of a nurse-led sexual rehabilitation intervention for women with gynaecological cancers receiving radiotherapy: results of a randomised trial

    Background

    The multicentre randomised SPARC trial evaluated the efficacy of a nurse-led sexual rehabilitation intervention on sexual functioning,...

    Isabelle Suvaal, Susanna B. Hummel, ... Moniek M. ter Kuile in British Journal of Cancer
    Article Open access 03 July 2024
  18. DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate cancer patients under active surveillance

    Background

    Current risk stratification tools for prostate cancer patients under active surveillance (AS) may inadequately identify those needing...

    Karolina Cyll, Erik Skaaheim Haug, ... Håvard E. Danielsen in British Journal of Cancer
    Article Open access 03 July 2024
Did you find what you were looking for? Share feedback.